Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice

Life Sciences

Volumn 65, Issue 2, 1999, Pages 157-164

  Wu, Wei Ran ^a   Zhu, Xing Zu ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

4 hydroxyquinoline; Dopamine; Fluorescence; Ginkgo biloba extract; Ginkgolide A; Ginkgolide B; HPLC; Kynuramine; Monoamine oxidase; MPTP; Striatum

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMINE OXIDASE (FLAVIN CONTAINING); DOPAMINE; GINKGO BILOBA EXTRACT; GINKGOLIDE A; GINKGOLIDE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TOXICITY; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; GINKGO BILOBA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NERVE REGENERATION; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN;

ANIMALIA; GINKGO BILOBA;

EID: 0033523067     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00232-5     Document Type: Article

References (29)

1. P.G. Barquet, A. Esanu, E. Busine, D. Hosford, C. Broquet and M. Koltai, Med. Res. Rev. 11 295-355 (1991).
2. M. Koltai, P. Guinot, D. Hosford and P.G. Barquet, Adv. Pharmacol. 28 81-167 (1994).
3. K. Kamata, T. Mori, K. Shigenobu and Y. Kasuya, Br. J. Pharmacol. 98 1360-1364 (1989).
4. S.S. Chatterjee and B. Gabard, Arch. Pharmacol. 319 (Suppl.) 57 (1982).
5. Y. Ni, B. Zhao, J. Hou and W. Xin, Neurosci. Lett. 214 115-118 (1996).
6. P. Halama, G. Bartsch and G. Meng, Fortschr.med. 106 408-412 (1988).
7. G. Vorberg, Clin. Trials J. 22 149-157 (1985).
8. S. Kanowski, W.M. Herrmann, K. Stephan, W. Wierich and R. Horr, Pharmacopsychiatry 29 47-56 (1996).
9. U. Bauer, Drug Res. 34 716-720 (1984).
10. S.P. Clissold, S. Lynch and E.M. Sorkin, Drugs 33 430-460 (1987).
11. V. Baschek and W. Steinert, Vertigo, Nausea, Tinnitus and Hypoacusia in Metabolic Disorders, C.F. Claussen, M.V. Kirtane and K. Schlitter (Eds.), 575-582, Elsevier Press, Amsterdam (1988).
12. M. Lacour, L. Ez-Zaher and J. Raymond, Pharmacol. Biochem. Behav. 40 367-379 (1991).
13. G. Smith, Brain Res. Rev. 13 103-118 (1988).
14. J.M. McCrodden, K.F. Tipton and J.P. Sullivan, Pharmacol. Toxicol. 67 8-13 (1990).
15. J.A. Javitch, R.J. D'Amato, S.M. Shittmatter and S.H. Snyder, Proc. Natl. Acad. Sci. USA 82 2173-2177 (1985).
16. X-Z. Zhu and L-G. Luo, J. Neurochem. 59 932-935 (1992).
17. M.A.K. Markwell, S.M. Hass, L.L. Bieber and N.E. Tolbert, Anal. Biochem. 87 206-210 (1978).
18. I. Mahmood, S.H. Neau and W.D. Mason, J. Pharmac. Biomed. Anal. 12 895-899 (1994).
19. P. G. Braquet, Drugs Future 12 643-699 (1987).
20. F.V. Defeudis, Ginkgo Biloba Extract (EGb 761): Pharmacological Activities and Clinical Applications, F.V. Defeudis (Eds.), 97-138, Elsevier Press, Paris (1991).
21. J.W. Langston, Eur. Neurol. 26 (Suppl. 1) 2-10 (1989).
22. H.C. Hung and E.H. Lee, Brain Res. Mol. Brain Res. 41 14-26 (1996).
23. H.C. Hung and E.H. Lee, Free Radic. Biol. Med. 24 76-84 (1998).
24. W.-R. Wu, X.Z. Zhu, H.-J. Guan, R.-G. Wang and X.-Q. Ji, Acta. Pharmacol. Sin. 20 in press (1999).
25. J.W. Langston, L.S. Forno, C.S. Rebert and I. Irwin, Brain Res. 292 390-394 (1984).
26. J.W. Langston, P. Ballard, J.W. Tetrud and I. Irwin, Science 219 979-980 (1983).
27. C.C. Chiueh, J.N. Johannessen, J.L. Sun, J.P. Bacon and S.P. Markey, MPTP: A Neurotoxin Producing a Parkinsonian Syndrome. S.P. Markey, N. Castagnoli, A.J. Trevor and I.J. Kopin, (Eds.), 473-479, Academic Press, New York (1986).
28. C. Ramassamy, F. Clostre, Y. Christen and J. Costentin, Effects of Ginkgo Biliba Extract (EGb 761) on the Central Nervous System, Y. Christen, J. Costentin and M. Lacour (Eds.), 27-36, Elsevier Press, Paris (1992).
29. E.A. Johnson, E.Y. Wu, H. Rollema, R.G. Booth, A.J. Trevor and N. Castagnoli, Eur. J. Pharmacol. 166 65-74 (1989).